cAMP-activated protein kinase-independent potentiation of insulin secretion by cAMP is impaired in SUR1 null islets

Diabetes

Volumn 51, Issue 12, 2002, Pages 3440-3449

  Nakazaki, Mitsuhiro ^a,b   Crane, Ana ^a   Hu, Min ^a   Seghers, Victor ^a   Ullrich, Susanne ^a,c   Aguilar Bryan, Lydia ^a   Bryan, Joseph ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUCAGON LIKE PEPTIDE 1; INSULIN; KT 5720; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; POTASSIUM CHANNEL; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE HOMEOSTASIS; HYPOGLYCEMIA; INSULIN RELEASE; MOUSE; NONHUMAN; PANCREAS ISLET CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0036895635     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.12.3440     Document Type: Article

References (63)

1. Aguilar-Bryan L, Bryan J: Molecular biology of adenosine triphosphate-sensitive potassium channels. Endocr Rev 20:101-135, 1999
2. Bryan J, Aguilar-Bryan L: Sulfonylurea receptors, ATP-sensitive potassium channels and insulin secretion. In Diabetes Mellitus. 2nd Ed. LeRoith D, Taylor SI, Olefsky JM, Eds. Philadelphia, Lippincott-Raven, 2000, p. 61-78
3. Kaiser N, Corcos AP, Tur SA, Ariav Y, Glaser B, Landau H, Cerasi E: Regulation of insulin release in persistent hyperinsulmaemic hypoglycaemia of infancy studied in long-term culture of pancreatic tissue. Diabetologia 33:482-488, 1990
4. ATP channel-independent pathways. Diabetes 50:329-339, 2001
5. ATP channel-deficient mice. Proc Natl Acad Sci U S A 95:10402-10406, 1998
6. ATP channel-independent regulation of insulin secretion. J Biol Chem 275:9270-9277, 2000
7. Dunne MJ, Kane C, Shepherd RM, Sanchez JA, James RFL, Johnson PRV, Aynsley-Green A, Lu S, Clement IV JP, Lindley KJ, Seino S, Agullar-Bryan L: Familial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor. N Engl J Med 336:703-706, 1997
8. Thorens B: Glucagon-like peptide-1 and control of insulin secretion. Diabete Metab 21:311-318, 1995
9. Kakei M, Nakazaki M, Kamisaki T, Nagayama I, Fukamachi Y, Tanaka H: Inhibition of the ATP-sensitive potassium channel by class I antiarrhythmic agent, cibenzoline, in rat pancreatic beta-cells. Br J Pharmacol 109:1226-1231, 1993
10. Sutton R, Peters M, McShane P, Gray DW, Morris PJ: Isolation of rat pancreatic islets by ductal injection of collagenase. Transplantation 42:689-691, 1986
11. Komatsu M, Aizawa T, Yokokawa N, Sato Y, Okada N, Takasu N, Yamada T: Mastoparan-induced hormone release from rat pancreatic islets. Endocrinology 130:221-228, 1992
12. Maller JL, Kemp BE, Krebs EG: In vivo phosphorylation of a synthetic peptide substrate of cyclic AMP-dependent protein kinase. Proc Natl Acad Sci U S A 75:248-251, 1978
13. Walsh DA, Ashby CD, Gonzalez C, Calkins D, Fischer EH, Krebs EG: Purification and characterization of a protein inhibitor of adenosine 3',5'-monophosphate-dependent protein kinases. J Biol Chem 246:1977-1985, 1971
14. Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Naito K, Toshioka T, Hidaka H: Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino) ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem 265:5267-5272, 1990
15. Goke R, Goke B, Richter G, Arnold R: The entero-insular axis: The new incretin candidate glucagon-like peptide-1(7-36)amide (GLP-1(7-36)) amide (Review Article, German). Z Gastroenterol 26:715-719, 1988
16. Persson K, Gingerich RL, Nayak S, Wada K, Wada E, Ahren B: Reduced GLP-1 and insulin responses and glucose intolerance after gastric glucose in GRP receptor-deleted mice. Am J Physiol Endocrinol Metab 279:E956-E962, 2000
17. Eng J, Kleinman WA, Singh L, Singh G, Raufman JP: Isolation and characterization of exendin4, an exendin-3 analogue, from Heloderma suspectum venom: Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J Biol Chem 267:7402-7405, 1992
18. Ämmälä C, Dukes ID, Gengo P, Aguilar-Bryan L,Bryan J, Seghers VJ, Nakazaki M: Spontaneous oscillations in cytosolic calcium in islets from knockout mice lacking the sulphonylurea receptor-1 (SUR1) (Abstract). Diabetes 49 (Suppl. 1):A62, 2000
19. Ämmälä C, Aguilar-Bryan L, Bryan J, Dukes ID: Glucose modulation of intracellular calcium, electrical activity and insulin secretion in Surl null islets. Diabetes 50:A350-A351, 2001
20. + channels in mouse β cells. J Clin Invest 89:1288-1295, 1992
21. + channel-independent, insulinotropic action of glucose in the B-cells. Endocr Regul 26:159-162, 1992
22. +) permeability. Biochem Pharmacol 43:2483-2485, 1992
23. 2+ in rat pancreatic islets. Proc Natl Acad Sci U S A 92:10728-10732, 1995
24. Aizawa T, Komatsu M, Asanuma N, Sato Y, Sharp GW: Glucose action 'beyond ionic events' in the pancreatic beta cell. Trends Pharmacol Sci 19:496-499, 1998
25. Corkey BE, Glennon MC, Chen KS, Deeney JT, Matschinsky FM, Prentld M: A role for malonyl-CoA in glucose-stimulated insulin secretion from clonal pancreatic beta-cells. J Biol Chem 264:21608-21612, 1989
26. Prentld M, Corkey BE: Are the β-cell signaling molecules malonyl-CoA and cystolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? Diabetes 45:273-283, 1996
27. Chiba T, Yamatani T, Kadowald S, Yamaguchi A, Inui T, Saito Y, Fujita T: Glucose stimulates insulin release without altering cyclic AMP production or inositolphospholipid turnover in freshly obtained human insulinoma cells. Biochem Biophys Res Commun 145:263-268, 1987
28. Persaud SJ, Jones PM, Howell SL: Glucose-stimulated insulin secretion is not dependent on activation of protein kinase A. Biochem Biophys Res Commun 173:833-839, 1990
29. Renstrom E, Eliasson L, Rorsman P: Protein kinase A-dependent and -independent stimulation of exocytosis by cAMP in mouse pancreatic B-cells. J Physiol 502:105-118, 1997
30. Ding WG, Gromada J: Protein kinase A-dependent stimulation of exocytosis in mouse pancreatic beta-cells by glucose-dependent insulinotropic polypeptide. Diabetes 46:615-621, 1997
31. Lester LB, Langeberg LK, Scott JD: Anchoring of protein kinase A facilitates hormone-mediated insulin secretion. Proc Natl Acad Sci U S A 94:14942-14947, 1997
32. Lester LB, Faux MC, Nauert JB, Scott JD: Targeted protein kinase A and PP-2B regulate insulin secretion through reversible phosphorylation. Endocrinology 142:1218-1227, 2001
33. Gromada J, Bokvist K, Ding WG, Holst JJ, Nielsen JH, Rorsman P: Glucagon-like peptide 1 (7-36) amide stimulates exocytosis in human pancreatic β-cells by both proximal and distal regulatory steps in stimulus-secretion coupling. Diabetes 47:57-65, 1998
34. Ozald N, Shibasald T, Kashima Y, Mild T, Takahashi K, Ueno H, Sunaga Y, Yano H, Matsuura Y, Iwanaga T, Takai Y, Seino S: cAMP-GEFII is a direct target of cAMP in regulated exocytosis. Nat Cell Biol 2:805-811, 2000
35. 2+ release in INS-1 pancreatic beta-cells. J Physiol 536:375-385, 2001
36. Kashima Y, Miki T, Shibasaki T, Ozaki N, Miyazaki M, Yano H, Seino S: Critical role of cAMP-GEFII-Rim2 complex in incretin-potentiated insulin secretion. J Biol Chem 276:46046-46053, 2001
37. Richards JS: New signaling pathways for hormones and cyclic adenosine 3',5'-monophosphate action in endocrine cells. Mol Endocrinol 15:209-218, 2001
38. Kase H, Iwahashi K, Nakanishi S, Matsuda Y, Yamada K, Takahashi M, Murakata C, Sato A, Kaneko M: K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kidnases. Biochem Biophys Res Commun 142:436-440, 1987
39. Rothermel JD, Parker Botelho LH: A mechanistic and kinetic analysis of the interactions of the diastereoisomers of adenosine 3',5'-(cyclic)phosphorothioate with purified cyclic AMP-dependent protein kidnase. Biochem J 251:757-762, 1988
40. Dostmann WR: (RP)-cAMPS inhibits the cAMP-dependent protein kinase by blocking the cAMP-induced conformational transition. FEBS Lett 375:231-234, 1995
41. de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A, Bos JL: Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396:474-477, 1998
42. Kawasald H, Springett GM, Mochizuld N, Told S, Nakaya M, Matsuda M, Housman DE, Graybiel AM: A family of cAMP-binding proteins that directly activate Rap1. Science 282:2275-2279, 1998
43. Kraemer A, Rehmann HR, Cool RH, Theiss C, de Rooij J, Bos JL, Wittinghofer A: Dynamic interaction of cAMP with the Rap guanine-nucleotide exchange factor Epacl. J Mol Biol 306:1167-1177, 2001
44. Andrisani OM: CREB-mediated transcriptional control. Crit Rev Eukaryot Gene Expr 9:19-32, 1999
45. Bernal-Mizrachi E, Wice B, Inoue H, Permutt MA: Activation of serum response factor in the depolarization induction of Egr-1 transcription in pancreatic islet beta-cells. J Biol Chem 275:25681-25689, 2000
46. Yokokawa N, Komatsu M, Takeda T, Aizawa T, Yamada T: Mastoparan, a wasp venom, stimulates insulin release by pancreatic islets through pertussis toxin sensitive GTP-binding protein. Biochem Biophys Res Commun 158:712-716, 1989
47. Jones PM, Mann FM, Persaud SJ, Wheeler-Jones CP: Mastoparan stimulates insulin secretion from pancreatic beta-cells by effects at a late stage in the secretory pathway. Mol Cell Endocrinol 94:97-103, 1993
48. Straub SG, James RF, Dunne MJ, Sharp GW: Glucose augmentation of mastoparan-stimulated insulin secretion in rat and human pancreatic islets. Diabetes 47:1053-1057, 1998
49. 2+-independent late site in stimulus-secretion coupling: Studies with the RINm5F beta-cell line. J Biol Chem 268:23297-23306, 1993
50. Holz GGt, Kuhtreiber WM, Habener JF: Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37). Nature 361:362-365, 1993
51. ATP channel: separate roles of Kir6.2 and SUR1 subunit phosphorylation. EMBO J 18:4722-4732, 1999
52. Light PE, Bladen C, Winkfein RJ, Walsh MP, French RJ: Molecular basis of protein kinase C-induced activation of ATP-sensitive potassium channels. Proc Natl Acad Sci U S A 97:9058-9063, 2000
53. + channels by G-protein βy-subunits. EMBO J 19:4915-4925, 2000
54. + channel activity by GLP-1 in rat pancreatic beta-cells. Pflugers Arch 440:566-572, 2000
55. Bode HP, Moormann B, Dabew R, Goke B: Glucagon-like peptide 1 elevates cytosolic calcium in pancreatic beta-cells independently of protein kinase A. Endocrinology 140:3919-3927, 1999
56. 2+-independent insulin secretion from permeabilized RINm5F cells. J Biol Chem 262:5049-5056, 1987
57. Wang Y, Perfetti R, Greig NH, Holloway HW, DeOre KA, Montrose-Rafizadeh C, Elahi D, Egan JM: Glucagon-like peptide-1 can reverse the age-related decline in glucose tolerance in rats. J Clin Invest 99:2883-2889, 1997
58. D'Alessio DA, Kahn SE, Leusner CR, Ensinck JW: Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal. J Clin Invest 93:2263-2266, 1994
59. Villanueva-Penacarrillo ML, Alcantara AI, Clemente F, Delgado E, Valverde I: Potent glycogenic effect of GLP-1(7-36)amide in rat skeletal muscle. Diabetologia 37:1163-1166, 1994
60. Bullock BP, Heller RS, Habener JF: Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology 137:2968-2978, 1996
61. Toft-Nielson M, Madsbad S, Holst JJ: The effect of glucagon-like peptide I (GLP-1) on glucose elimination in healthy subjects depends on the pancreatic glucoregulatory hormones. Diabetes 45:552-556, 1996
62. Scrocchi LA, Marshall BA, Cook SM, Brubaker PL, Drucker DJ: Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling. Diabetes 47:632-639, 1998
63. Ma YH, Wang J, Rodd GG, Bolaffi JL, Grodsky GM: Differences in insulin secretion between the rat and mouse: Role of cAMP. Eur J Endocrinol 132:370-376, 1995